Parkinson's disease therapy(BenevolentAI Ltd)(Parkinson's disease therapy(BenevolentAI Ltd))

概要

基本信息

药物类型

小分子化药

别名-

靶点-

作用机制-

治疗领域

神经系统疾病内分泌与代谢疾病

在研适应症

帕金森病

非在研适应症-

原研机构

BenevolentAI Ltd.

在研机构

BenevolentAI Ltd.

非在研机构-

最高研发阶段药物发现

首次获批日期-

最高研发阶段(中国)-

特殊审评-

关联

100 项与 Parkinson's disease therapy(BenevolentAI Ltd) 相关的临床结果

登录后查看更多信息

100 项与 Parkinson's disease therapy(BenevolentAI Ltd) 相关的转化医学

登录后查看更多信息

100 项与 Parkinson's disease therapy(BenevolentAI Ltd) 相关的专利（医药）

登录后查看更多信息

4

项与 Parkinson's disease therapy(BenevolentAI Ltd) 相关的文献（医药）

2019-12-01·AJN, American Journal of Nursing4区 · 医学

Parkinson's Drug Doesn't Increase Prostate Cancer Risk

4区 · 医学

Article

作者: Aschenbrenner, Diane S

The Food and Drug Administration (FDA) has determined that entacapone, used in the management of Parkinson's disease, does not increase the risk of prostate cancer or death from prostate cancer.

The decision was based on an analysis of data from a postmarketing clinical trial conducted by the drug manufacturer and an FDA review of data from the Department of Veterans Affairs.

2014-03-01·Lab Animal

Parkinson's drug could treat diabetic retinopathy

作者: Rosania, Kara

2013-12-01·Nature Reviews Drug Discovery1区 · 医学

Parkinson's drug promotes myelin repair

1区 · 医学

Article

作者: Crunkhorn, Sarah

100 项与 Parkinson's disease therapy(BenevolentAI Ltd) 相关的药物交易

登录后查看更多信息